# TOPIRAMATE
> **ANDA220041** · Abbreviated New Drug Application (Generic) · Sponsor: RICONPHARMA LLC · Approved 2026-05-26
## Drug
- **FDA Application Number:** ANDA220041
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOPIRAMATE
- **Generic name:** Topiramate
- **Active ingredients:** TOPIRAMATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** RICONPHARMA LLC
- **First approval:** 2026-05-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220041)
---
*MORVS · CC0 1.0*